Replimune Group, Inc. (REPL)
NASDAQ: REPL · IEX Real-Time Price · USD
-1.10 (-11.58%)
Jun 14, 2024, 4:00 PM EDT - Market closed

Replimune Group Market Cap

Replimune Group has a market cap or net worth of $513.74 million as of June 14, 2024. Its market cap has decreased by -60.58% in one year.

Market Cap
Enterprise Value
1-Year Change
Stock Price

Market Cap Chart

Since July 20, 2018, Replimune Group's market cap has increased from $467.50M to $513.74M, an increase of 9.89%. That is a compound annual growth rate of 1.61%.


DateMarket Cap% Change
Jun 14, 2024513.70M-11.58%
Jun 13, 2024581.00M7.25%
Jun 12, 2024541.70M-1.99%
Jun 11, 2024552.70M-
Jun 10, 2024552.70M13.91%
Jun 7, 2024485.20M11.11%
Jun 6, 2024436.70M27.88%
Jun 5, 2024341.50M9.67%
Jun 4, 2024311.40M-6.79%
Jun 3, 2024334.10M3.21%
May 31, 2024323.70M3.35%
May 30, 2024313.20M1.79%
May 29, 2024307.70M-3.27%
May 28, 2024318.10M-0.78%
May 24, 2024320.60M-7.77%
May 23, 2024347.60M-4.56%
May 22, 2024364.20M6.46%
May 21, 2024342.10M-6.22%
May 20, 2024364.80M-7.76%
May 17, 2024395.50M-4.17%
May 16, 2024412.70M-1.29%
May 15, 2024418.10M1.51%
May 14, 2024411.90M1.83%
May 13, 2024404.50M2.80%
May 10, 2024393.50M-4.74%
View and export this data all the way back to 2018. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Exscientia 601.16M
Applied Therapeutics 601.04M
Surmodics 598.92M
Arbutus Biopharma 596.35M
iTeos Therapeutics 588.80M
Fulgent Genetics 580.23M
Pharming Group 578.92M
Canopy Growth 568.43M
Market Cap Rankings